Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.

Journal of clinical pathology - 1 Jan 2016

Rack Katrina, Vidrequin Sébastien, Dargent Jean-Louis

Abstract excerpt

BACKGROUND: Chromosome abnormalities are important prognostic factors in myeloma allowing risk stratification of patients. Different techniques are available for their detection including cytogenetics, Fluorescent In Situ Hybridisation (FISH) and array Competitive Genomic Hybridisation (CGH). This study aimed to assess the validity and usefulness of each technique in a diagnostic setting. METHODS: 112 myeloma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Chromosomes, Human

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Comparative Genomic Hybridization

Share to Cytogenetic Analysis

Share to In Situ Hybridization, Fluorescence

Share to Multiple Myeloma

Share to Ploidies

Share to Translocation, Genetic

Source

Identifiers

PMID: 26338801
DOI: 10.1136/jclinpath-2015-203054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.PMID 26338801Read ↗

Recent advances in cytogenetic characterization of multiple myelomaSemantic proximity Read ↗

Multiple Myeloma Genomics – A Concise ReviewSemantic proximity Read ↗

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read ↗

Genomic profiling of multiple myeloma: New insights and modern technologies.Semantic proximity Read ↗

Chromosomal defects in multiple myelomaSemantic proximity Read ↗

Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working GroupSemantic proximity Read ↗

Plasma Cell Enrichment and New Genomic Approaches in Multiple Myeloma: A Scoping ReviewSemantic proximity Read ↗

Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaSemantic proximity Read ↗

Interpretation of cytogenetic results in multiple myeloma for clinical practiceSemantic proximity Read ↗

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.Semantic proximity Read ↗

Cytogenetics helps determine diagnosis and prognosis for multiple myeloma.Semantic proximity Read ↗

Recurrent Cytogenetic Abnormalities in Multiple Myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.